![Daniella Beckman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 30/06/2026
Daniella Beckman is Lead Independent Director at Vor Biopharma, Inc. since 2026 and Independent Director at Upstream Bio, Inc. since 2024.
Former roles include Independent Director at Blueprint Medicines Corp.
from 2021 to 2025, Independent Director at 5:01 Acquisition Corp.
from 2020 to 2022, Independent Director at Translate Bio, Inc. from 2017 to 2021, Chief Financial Officer & PAO at Tango Therapeutics, Inc. from 2016 to 2026, Chief Financial Officer at BioNTech US, Inc. from 2015 to 2019, Chief Financial Officer at Beckman Consulting LLC from 2015 to 2019, CFO, Treasurer, Director & Vice President at Idenix Pharmaceuticals LLC from 2011 to 2014.
Education includes undergraduate studies at Boston University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 131.689 ( 0,12% ) | 4 M $ | 30/06/2026 | |
UPSTREAM BIO, INC. -.--% | 09/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
VOR BIOPHARMA, INC. -.--% | 11/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VOR BIOPHARMA INC. | Direttore/Membro del Consiglio | 16/07/2020 |
| UPSTREAM BIO, INC. | Direttore/Membro del Consiglio | 11/10/2024 |
| Società | Posizione | Fine |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 15/04/2026 |
| BLUEPRINT MEDICINES CORPORATION | Direttore/Membro del Consiglio | 17/07/2025 |
| 501 ACQU | Direttore/Membro del Consiglio | 01/01/2022 |
| TRANSLATE BIO, INC. | Direttore/Membro del Consiglio | 14/09/2021 |
| NEON THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/09/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of human viral and infectious diseases caused by hepatitis | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Beckman Consulting LLC
 Beckman Consulting LLC Miscellaneous Commercial ServicesCommercial Services Engages in the provision of consulting services | Commercial Services |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
